HEMAFLAT
Board
1 director, 2 in day-to-day management, last change in 2025Chair of the board and managing director
chair of the board appointed by deed of 22-01-2025
managing director appointed by deed of 18-09-2015
earlier director, until 22-01-2025
listed in the 2025 annual accounts, filed on 27-08-2026
Managing director
in office according to the deed of 22-01-2025
earlier director, from 21-12-2017 to 22-01-2025
- ,
Mandates through the years
2 names, the dashed line is todayManaging director, Chair of the board
Managing director
LeadershipEarliermandate already running before its first mention
Mandates as a list
-
- Managing director, appointed by deed of 10-10-2007, still in office
- Director, from before 18-09-2015 to 22-01-2025
- Chair of the board, appointed by deed of 22-01-2025, still in office
-
- Director, appointed by deed of 22-01-2018, until 22-01-2025
- Managing director, since before 22-01-2025
With Starter you also see 4 former office holders in the mandate history.
See the plans →
Control
Capital
- Capital
- €62,000
- Shares
- 500
- Contribution per share
- €124
- Equity per share
- €2,197 in 2025
- Source
- deed of 22-01-2025
Articles of association
deed of 22-01-2025 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- Raad, 6 jaar
Capital transactions
Capital over time
- 22-01-2025 Capital stated in the deed · €62,000 · 500 shares
- 22-01-2018 Capital reduction of €61,946.76 · to €62,000 · repaid to the shareholders